Here are the DEF 14A proxy statements from Anixa Biosciences, Inc. (ANIX) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow ANIX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ANIX filings page.
Anixa Biosciences, Inc. is asking stockholders to vote at its 2026 Annual Meeting, which will be held virtually on March 10, 2026 at 10:00 a.m. Pacific time. Stockholders of record as of January 13, 2026, when 33,379,505 common shares were outstanding, may vote.
Investors are being asked to elect four directors (Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk and Lewis H. Titterton Jr.) for one-year terms, approve on a non-binding, advisory basis the compensation of the named executive officers, and ratify Haskell & White LLP as independent registered public accounting firm for the fiscal year ending October 31, 2026.
The Board unanimously recommends voting “FOR” all four director nominees, “FOR” the advisory say‑on‑pay proposal, and “FOR” ratification of the auditor. The proxy explains how to vote by internet, telephone, mail, or at the virtual meeting, and details board committees, governance practices, and executive and director compensation.